CA Stock MarketDetailed Quotes
NRX NurExone Biologic Inc
- 0.720
- -0.030-4.00%
15min DelayTrading Jul 3 11:49 ET
48.32MMarket Cap-6545P/E (TTM)
0.720High0.690Low35.85KVolume0.710Open0.750Pre Close24.99KTurnover1.19052wk High0.06%Turnover Ratio67.11MShares0.18552wk Low-0.11EPS TTM45.05MFloat Cap1.190Historical HighLossP/E (Static)62.57MShs Float0.100Historical Low-0.107EPS LYR4.00%Amplitude--Dividend TTM9.73P/B1Lot Size--Div YieldTTM
NurExone Biologic Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 27.96%920K | -34.00%3.66M | -14.86%716K | 17.81%1.16M | -28.57%1.06M | -67.73%719K | 223.47%5.54M | -6.97%841K | 263.24%988K | 1.48M |
| Selling and administrative expenses | 101.45%695K | -49.35%2.1M | -12.67%386K | 34.63%762K | -48.94%603K | -82.28%345K | 262.81%4.14M | -27.18%442K | 142.92%566K | --1.18M |
| -General and administrative expense | 101.45%695K | -49.35%2.1M | -12.67%386K | 34.63%762K | -48.94%603K | -82.28%345K | 262.81%4.14M | -27.18%442K | 142.92%566K | --1.18M |
| Research and development costs | -39.84%225K | 10.78%1.54M | -19.74%309K | -4.74%402K | 50.83%457K | 33.10%374K | 142.76%1.39M | 29.63%385K | 982.05%422K | --303K |
| Depreciation amortization depletion | ---- | 50.00%21K | ---- | ---- | ---- | ---- | --14K | ---- | ---- | ---- |
| -Depreciation and amortization | ---- | 50.00%21K | ---- | ---- | ---- | ---- | --14K | ---- | ---- | ---- |
| Operating profit | -27.96%-920K | 34.00%-3.66M | 14.86%-716K | -17.81%-1.16M | 28.57%-1.06M | 67.73%-719K | -223.47%-5.54M | 6.97%-841K | -263.24%-988K | -1.48M |
| Net non-operating interest income (expenses) | -114.29%-2K | 333.33%42K | -99.16%3K | 142.86%6K | 107.25%20K | 116.09%14K | -38.46%-18K | 548.75%359K | -275.00%-14K | -276K |
| Non-operating interest expense | ---- | -90.91%3K | ---- | ---- | ---- | ---- | 175.00%33K | ---- | ---- | ---- |
| Total other finance cost | 114.29%2K | -200.00%-45K | 98.47%-6K | -142.86%-6K | -107.25%-20K | -116.09%-14K | -1,600.00%-15K | -676.47%-392K | 275.00%14K | --276K |
| Other net income (expenses) | 99.08%-24K | -3,403.80%-2.61M | -532K | -39K | -2.04M | |||||
| Gain on sale of security | ---- | 99.57%-2K | ---- | ---- | ---- | ---- | -689.87%-466K | ---- | ---- | ---- |
| Special income (charges) | ---- | --0 | --0 | --0 | --0 | ---- | ---2.08M | --0 | ---39K | ---2.04M |
| -Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | --0 | --0 | ---- | --2.08M | --0 | --39K | --2.04M |
| Other non-operating income (expenses) | ---- | 66.67%-22K | ---- | ---- | ---- | ---- | ---66K | ---- | ---- | ---- |
| Income before tax | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M | -294.32%-1.04M | -3.8M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M | -294.32%-1.04M | -3.8M |
| Net income continuous operations | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M | -294.32%-1.04M | ---3.8M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M | -294.32%-1.04M | -3.8M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -30.78%-922K | 55.45%-3.64M | 27.32%-737K | -11.24%-1.16M | 72.62%-1.04M | 69.55%-705K | -395.99%-8.17M | -12.04%-1.01M | -294.32%-1.04M | -3.8M |
| Diluted earnings per share | 0.00%-0.016 | 62.50%-0.081 | 0.00%-0.015 | 13.33%-0.026 | 79.31%-0.024 | 70.71%-0.016 | -455.86%-0.216 | 29.75%-0.015 | -381.62%-0.03 | -0.116 |
| Basic earnings per share | 0.00%-0.016 | 62.50%-0.081 | 0.00%-0.015 | 13.33%-0.026 | 79.31%-0.024 | 70.71%-0.016 | -455.86%-0.216 | 29.75%-0.015 | -381.62%-0.03 | -0.116 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg